Pneumococcal Disease Vaccine Update

Published Online: Monday, January 30, 2012
Follow Pharmacy_Times:
A vaccine was developed in 2000 which substantially decreased the number of invasive pneumococcal disease cases. Recently, a new vaccine was approved and is expected to prevent even more cases of this serious disease. In this In this patient-friendly podcast, Dr. Pekka Nuorti discusses the new vaccine to prevent invasive pneumococcal disease.

To hear more about the new and improved vaccine, click here.
Related Articles
A reduction in pediatric health care visits related to otitis media between 2001 and 2011 appears to be due to uptake of the pneumococcal conjugate vaccine, according to the results of a new study.
A new study finds that decreased rates of infection with serotypes of pneumococcal disease the PCV7 vaccine protects against outweigh increased rates of infection with serotypes it does not protect against.
Streptococcus pneumoniae is the leading cause of life-threatening illness globally.
A decade after the 7-valent pneumococcal conjugate vaccine was introduced, it led to approximately 168,000 fewer annual hospitalizations for pneumonia.
Latest Issues
$auto_registration$